Paxlovid (nirmatrelvir; ritonavir) - Important Safety Information from Pfizer Healthcare Ireland as approved by the HPRA (21.03.24)

Notice type: 3rd Party Publications

Date: 20/03/2024




Problem Or Issue:

Important Safety Information from Pfizer Healthcare Ireland regarding PAXLOVID (nirmatrelvir; ritonavir): reminder of life-threatening and fatal drug-drug interactions with certain immunosuppressants, including tacrolimus


Important Safety Information – PAXLOVID (nirmatrelvir; ritonavir)


« Back